Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2017, Article ID 5789769, 11 pages
https://doi.org/10.1155/2017/5789769
Research Article

Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas

1The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA
2Department of Biochemistry, School of Medicine, Gachon University, Incheon 21936, Republic of Korea
3Department of Microbiology, Chonnam National University Medical School, 160, Baekseo-ro, Dong-gu, Gwangju 61469, Republic of Korea
4Department of Surgery, School of Medicine, Keimyung University, 1095 Dalgubeol-daero, Dalseo-gu, Daegu 42601, Republic of Korea
5Department of Pathology, School of Medicine, Keimyung University, 1095 Dalgubeol-daero, Dalseo-gu, Daegu 42601, Republic of Korea
6Department of Immunology, School of Medicine & Institute of Medical Science, Keimyung University, 1095 Dalgubeol-daero, Dalseo-gu, Daegu 42601, Republic of Korea

Correspondence should be addressed to Shin Kim; rk.ro.cmsd@50089dog and Jong-Wook Park; rk.ro.cmsd@hin303j

Received 2 September 2016; Revised 8 December 2016; Accepted 11 January 2017; Published 2 March 2017

Academic Editor: Mohamed Salem

Copyright © 2017 Jaegil Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Davies and H. G. Welch, “Current thyroid cancer trends in the United States,” JAMA Otolaryngology—Head and Neck Surgery, vol. 140, no. 4, pp. 317–322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. The Korea Central Cancer Registry (KCCR), Ministry of Health & Welfare, National Cancer Center, Ministry of Health & Welfare, Korea Central Cancer Registry, National Cancer Center, 2014.
  3. Y.-K. Kim, B. Kim, and V. N. Kim, “Re-evaluation of the roles of DROSHA, Exportin 5, and DICER in microRNA biogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 13, pp. E1881–E1889, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Papachristou, A. Korpetinou, E. Giannopoulou et al., “Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas,” Virchows Archiv, vol. 459, no. 4, pp. 431–440, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Y. Han, S. Kim, D.-H. Shin, J. H. Cho, and S.-I. Nam, “The Expression of AGO2 and DGCR8 in idiopathic sudden sensorineural hearing loss,” Clinical and Experimental Otorhinolaryngology, vol. 7, no. 4, pp. 269–274, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kim, J.-H. Lee, and S.-I. Nam, “Dicer is down-regulated and correlated with drosha in idiopathic sudden sensorineural hearing loss,” Journal of Korean Medical Science, vol. 30, no. 8, pp. 1183–1188, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. C. S. Inchley, T. Sonerud, H. O. Fjærli, and B. Nakstad, “Reduced Dicer expression in the cord blood of infants admitted with severe respiratory syncytial virus disease,” BMC Infectious Diseases, vol. 11, article 59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Tao, H. Wu, Q. Lin et al., “Deletion of astroglial dicer causes non-cell autonomous neuronal dysfunction and degeneration,” Journal of Neuroscience, vol. 31, no. 22, pp. 8306–8319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Mori, T. Thomou, J. Boucher et al., “Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy,” The Journal of Clinical Investigation, vol. 124, no. 8, pp. 3339–3351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. W. M. Merritt, Y. G. Lin, L. Y. Han et al., “Dicer, Drosha, and outcomes in patients with ovarian cancer,” The New England Journal of Medicine, vol. 359, no. 25, pp. 2641–2650, 2008. View at Google Scholar
  12. M. G. Martin, J. E. Payton, and D. C. Link, “Dicer and outcomes in patients with acute myeloid leukemia (AML),” Leukemia Research, vol. 33, no. 8, Article ID e127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-F. Wu, W. Shen, N.-Z. Liu et al., “Down-regulation of Dicer in hepatocellular carcinoma,” Medical Oncology, vol. 28, no. 3, pp. 804–809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. A. Poursadegh Zonouzi, A. Nejatizadeh, M. Rahmati-Yamchi et al., “Dysregulated expression of Dicer in invasive ductal breast carcinoma,” Medical Oncology, vol. 32, no. 7, article 203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Flavin, P. C. Smyth, S. P. Finn et al., “Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients,” Modern Pathology, vol. 21, no. 6, pp. 676–684, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Zhang, M. Cairns, B. Rose et al., “Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland,” International Journal of Cancer, vol. 124, no. 12, pp. 2855–2863, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Chiosea, E. Jelezcova, U. Chandran et al., “Up-regulation of dicer, a component of the microRNA machinery, in prostate adenocarcinoma,” American Journal of Pathology, vol. 169, no. 5, pp. 1812–1820, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Muralidhar, L. D. Goldstein, G. Ng et al., “Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels,” Journal of Pathology, vol. 212, no. 4, pp. 368–377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Vincenzi, A. Zoccoli, G. Schiavon et al., “Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients,” European Journal of Cancer, vol. 49, no. 6, pp. 1501–1508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Torres, K. Torres, T. Paszkowski et al., “Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer,” Tumor Biology, vol. 32, no. 4, pp. 769–776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Vaksman, T. E. Hetland, C. G. Trope', R. Reich, and B. Davidson, “Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma,” Human Pathology, vol. 43, no. 11, pp. 2062–2069, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Shaikhibrahim, A. Lindstrot, J. Ochsenfahrt, K. Fuchs, and N. Wernert, “Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines,” International Journal of Molecular Medicine, vol. 31, no. 1, pp. 21–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Kim, J.-H. Lee, J. W. Park et al., “An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas,” Clinical and Experimental Medicine, vol. 14, no. 3, pp. 331–336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sand, M. Skrygan, D. Georgas et al., “Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer,” Molecular Carcinogenesis, vol. 51, no. 11, pp. 916–922, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Y. Kwon, J.-H. Lee, B. Kim et al., “Complexity in regulation of microRNA machinery components in invasive breast carcinoma,” Pathology and Oncology Research, vol. 20, no. 3, pp. 697–705, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Kim, “The dysregulation of microRNA machinery components in papillary thyroid cancer,” Keimyung Medical Journal, vol. 32, no. 1, pp. 29–35, 2013. View at Google Scholar
  27. E. Cerami, J. Gao, U. Dogrusoz et al., “The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data,” Cancer Discovery, vol. 2, no. 5, pp. 401–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. The Cancer Genome Atlas Research Network, “Integrated genomic characterization of papillary thyroid carcinoma,” Cell, vol. 159, no. 3, pp. 676–690, 2014. View at Publisher · View at Google Scholar
  29. T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the comparative CT method,” Nature Protocols, vol. 3, no. 6, pp. 1101–1108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Lin and R. I. Gregory, “MicroRNA biogenesis pathways in cancer,” Nature Reviews Cancer, vol. 15, no. 6, pp. 321–333, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. M. D. Jansson and A. H. Lund, “MicroRNA and cancer,” Molecular Oncology, vol. 6, pp. 590–610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Puppin, C. Durante, M. Sponziello et al., “Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation,” Endocrine, vol. 47, no. 2, pp. 528–536, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Erler, X. M. Keutgen, M. J. Crowley et al., “Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer,” Surgery, vol. 156, no. 6, pp. 1342–1350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Pampalakis, E. P. Diamandis, D. Katsaros, and G. Sotiropoulou, “Down-regulation of dicer expression in ovarian cancer tissues,” Clinical Biochemistry, vol. 43, no. 3, pp. 324–327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. T. D. Schmittgen, “Regulation of microRNA processing in development, differentiation and cancer,” Journal of Cellular and Molecular Medicine, vol. 12, no. 5B, pp. 1811–1819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Lee, J. Han, K.-H. Yeom, H. Jin, and V. N. Kim, “Drosha in primary microRNA processing,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 71, pp. 51–57, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. W. M. Merritt, M. Bar-Eli, and A. K. Sood, “The dicey role of dicer: implications for RNAi therapy,” Cancer Research, vol. 70, no. 7, pp. 2571–2574, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Mockenhaupt, N. Schürmann, and D. Grimm, “When cellular networks run out of control: global dysregulation of the RNAi machinery in human pathology and therapy,” Progress in Molecular Biology and Translational Science, vol. 102, pp. 165–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Faggad, A. Kasajima, W. Weichert et al., “Down-regulation of the microRNA processing enzyme dicer is a prognostic factor in human colorectal cancer,” Histopathology, vol. 61, no. 4, pp. 552–561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Sugito, H. Ishiguro, Y. Kuwabara et al., “RNASEN regulates cell proliferation and affects survival in esophageal cancer patients,” Clinical Cancer Research, vol. 12, no. 24, pp. 7322–7328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Karube, H. Tanaka, H. Osada et al., “Reduced expression of Dicer associated with poor prognosis in lung cancer patients,” Cancer Science, vol. 96, no. 2, pp. 111–115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. R.-J. Lin, Y.-C. Lin, J. Chen et al., “microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma,” Cancer Research, vol. 70, no. 20, pp. 7841–7850, 2010. View at Publisher · View at Google Scholar · View at Scopus